Shots: The P-III OPERA, ORATORIO and OBOE studies result involves assessing of Ocrevus (ocrelizumab) vs PBO in patients with RMS and PPMS, presented at AAN Annual Meeting Results: reduction in […]readmore
Tags : Primary Progressive Multiple Sclerosis